45 related articles for article (PubMed ID: 7830131)
1. New directions in pharmacologic stress imaging.
Iskandrian AS
J Nucl Med; 1995 Feb; 36(2):276-7. PubMed ID: 7830131
[No Abstract] [Full Text] [Related]
2. Effect of N-0861, a selective adenosine A1 receptor antagonist, on pharmacologic stress imaging with adenosine.
Glover DK; Ruiz M; Sansoy V; Barrett RJ; Beller GA
J Nucl Med; 1995 Feb; 36(2):270-5. PubMed ID: 7830130
[TBL] [Abstract][Full Text] [Related]
3. Realizing the potential of adenosine-receptor-based therapeutics.
Barrett RJ
Proc West Pharmacol Soc; 1996; 39():61-6. PubMed ID: 8895971
[No Abstract] [Full Text] [Related]
4. Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.
Martin PL; Wysocki RJ; Barrett RJ; May JM; Linden J
J Pharmacol Exp Ther; 1996 Feb; 276(2):490-9. PubMed ID: 8632314
[TBL] [Abstract][Full Text] [Related]
5. Selective attenuation by N-0861 (N6-endonorboran-2-yl-9-methyladenine) of cardiac A1 adenosine receptor-mediated effects in humans.
Bertolet BD; Belardinelli L; Franco EA; Nichols WW; Kerensky RA; Hill JA
Circulation; 1996 May; 93(10):1871-6. PubMed ID: 8635266
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A1-receptor occupancy predicts A1-receptor antagonist effects of N-0861.
Yasuda SU; Nagashima S; Douyon E; Benton RE; Woosley RL; Barbey JT
Clin Pharmacol Ther; 1998 Nov; 64(5):536-41. PubMed ID: 9834045
[TBL] [Abstract][Full Text] [Related]
7. [Hemodynamic effects of dobutamine and adenosine triphosphate in the ischemic canine heart].
Tateda T
Masui; 1986 Oct; 35(10):1505-12. PubMed ID: 3806941
[No Abstract] [Full Text] [Related]
8. (+-)-N6-endonorbornan-2-yl-9-methyladenine (N-0861) and its enantiomers: selective antagonists of A1-adenosine receptors in guinea pig isolated atria.
Martin PL; Potts AA; Sykes AM; McKenna DG
J Pharmacol Exp Ther; 1993 Apr; 265(1):201-6. PubMed ID: 8474007
[TBL] [Abstract][Full Text] [Related]
9. N(6) or N(9) substituted 2-phenyl-8-azaadenines: affinity for A1 adenosine receptors. VII.
Biagi G; Giorgi I; Livi O; Scartoni V; Breschi C; Martini C; Scatizzi R
Farmaco; 1995 Oct; 50(10):659-67. PubMed ID: 8590573
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
Nekooeian AA; Tabrizchi R
Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of apoptosis induced by purine nucleosides in astrocytes.
Di Iorio P; Kleywegt S; Ciccarelli R; Traversa U; Andrew CM; Crocker CE; Werstiuk ES; Rathbone MP
Glia; 2002 May; 38(3):179-90. PubMed ID: 11968056
[TBL] [Abstract][Full Text] [Related]
12. N(9)-Substituted 2-phenyl-N(6)-benzyl-8-azaadenines: A1 adenosine receptor affinity. A comparison with the corresponding N(6)-substituted 2-phenyl-N(9)-benzyl-8-azaadenines.
Biagi G; Giorgi I; Livi O; Scartoni V
Farmaco; 1996 Jun; 51(6):395-9. PubMed ID: 8845046
[TBL] [Abstract][Full Text] [Related]
13. [Effects of high-dose fentanyl on normal and ischemic heart].
Furuya Y; Morimoto S; Yokoyama S; Nagara M; Tanaka S; Fujita M
Masui; 1983 Oct; 32(10):1220-6. PubMed ID: 6668652
[No Abstract] [Full Text] [Related]
14. Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs.
Minamino T; Kitakaze M; Asanuma H; Tomiyama Y; Shiraga M; Sato H; Ueda Y; Funaya H; Kuzuya T; Matsuzawa Y; Hori M
J Clin Invest; 1998 Apr; 101(8):1643-53. PubMed ID: 9541494
[TBL] [Abstract][Full Text] [Related]
15. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins.
Zhao ZQ; Budde JM; Morris C; Wang NP; Velez DA; Muraki S; Guyton RA; Vinten-Johansen J
J Mol Cell Cardiol; 2001 Jan; 33(1):57-68. PubMed ID: 11133223
[TBL] [Abstract][Full Text] [Related]
16. Adrenomedullin mediates coronary vasodilation through adenosine receptors and KATP channels.
Sabates BL; Pigott JD; Choe EU; Cruz MP; Lippton HL; Hyman AL; Flint LM; Ferrara JJ
J Surg Res; 1997 Feb; 67(2):163-8. PubMed ID: 9073563
[TBL] [Abstract][Full Text] [Related]
17. The cardiovascular effects of adenosine: clinical use and nursing implications.
Teplitz L
Prog Cardiovasc Nurs; 1993; 8(2):20-8. PubMed ID: 7937680
[TBL] [Abstract][Full Text] [Related]
18. [Protection of ischemic myocardium by verapamil (author's transl)].
Nakamura Y; Hayashi J; Mori H; Ogawa S; Takahashi M; Hattori S; Ohosuzu F; Tanabe Y; Hara K
Kokyu To Junkan; 1981 Apr; 29(4):399-403. PubMed ID: 7255989
[No Abstract] [Full Text] [Related]
19. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
Martin PL; Ueeda M; Olsson RA
J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new 2-phenyladenines and 2-phenylpteridines and biological evaluation as adenosine receptor ligands.
Giorgi I; Biagi G; Livi O; Leonardi M; Scartoni V; Pietra D
Arch Pharm (Weinheim); 2007 Feb; 340(2):81-7. PubMed ID: 17294400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
